Ilana Teruszkin Balassiano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ilana Teruszkin Balassiano has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Estrela-Lima
Research Center on Mammary Oncology (NPqOM), Veterinary Medicine Hospital (HOSPMEV), Federal University of Bahia, Salvador, Brazil
1 shared publication - Amilton Clair Pinto Seixas Neto
Laboratório de Bacteriologia e Bioensaios, Departamento de Microbiologia e Parasitologia, Instituto de Biologia, Universidade Federal de Pelotas, Pelotas, RS, Brazil
1 shared publication Camila Hamond
Bacterial Disease Laboratory, Postgraduate Program in Animal Science in Tropics - Federal University of Bahia, Adhemar de Barros av, 500, 40170-110, Salvador, BA, Brazil
1 shared publication- Carla Silva Dias
Postgraduate Program in Animal Science in the Tropics - Federal University of Bahia
1 shared publication - Daiane Drawanz Hartwig
Laboratório de Bacteriologia e Bioensaios, LaBBio, Universidade Federal de Pelotas, UFPel, Pelotas, Brazil
1 shared publication Daniela Santos Almeida
Bacterial Disease Laboratory, Postgraduate Program in Animal Science in Tropics - Federal University of Bahia, Adhemar de Barros av, 500, 40170-110, Salvador, BA, Brazil
1 shared publication
Latest Publications
- 28 May 2024
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 55 (3) , 1-6
Advancing serologic diagnosis: assessing the efficacy of rErpY-like protein in human leptospirosis detection
Leptospirosis is a globally distributed infectious disease caused by pathogenic spirochetes of the Leptospira genus, often overlooked. It is estimated that the disease affects approximately one million people annually, resulting in more than 58,900 deaths. The gold standard for serodiagnosis of leptospirosis is the Microscopic Agglutination Test (MAT). However, the limitations of this technique necessitate the exploration of alternative diagnostic methods. In this study, we evaluated the ErpY-like recombinant protein (rErpY-like) in the development of a serologic diagnostic assay for human leptospirosis. Eighty-six human sera samples, characterized by MAT, underwent evaluation through indirect IgM-ELISA and IgG-ELISA. The sensitivity and specificity values obtained from IgM-ELISA were 60% and 76%, respectively, while those from IgG-ELISA were 96.4% and 100%, respectively. The use of the rErpY-like protein in both IgM-ELISA and IgG-ELISA proves to be a sensitive and specific method for antibody detection. This could potentially serve as a valuable alternative tool in the diagnosis of human leptospirosis.
- 28 May 2024
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 55 (3) , 1-6
Advancing serologic diagnosis: assessing the efficacy of rErpY-like protein in human leptospirosis detection
Leptospirosis is a globally distributed infectious disease caused by pathogenic spirochetes of the Leptospira genus, often overlooked. It is estimated that the disease affects approximately one million people annually, resulting in more than 58,900 deaths. The gold standard for serodiagnosis of leptospirosis is the Microscopic Agglutination Test (MAT). However, the limitations of this technique necessitate the exploration of alternative diagnostic methods. In this study, we evaluated the ErpY-like recombinant protein (rErpY-like) in the development of a serologic diagnostic assay for human leptospirosis. Eighty-six human sera samples, characterized by MAT, underwent evaluation through indirect IgM-ELISA and IgG-ELISA. The sensitivity and specificity values obtained from IgM-ELISA were 60% and 76%, respectively, while those from IgG-ELISA were 96.4% and 100%, respectively. The use of the rErpY-like protein in both IgM-ELISA and IgG-ELISA proves to be a sensitive and specific method for antibody detection. This could potentially serve as a valuable alternative tool in the diagnosis of human leptospirosis.